Risk of venous thromboembolism with a central venous catheter in hospitalized Japanese patients with inflammatory bowel disease: a propensity score-matched cohort study.
Asia
Central venous catheter
Inflammatory bowel disease
Thromboprophylaxis
Venous thromboembolism
Journal
Intestinal research
ISSN: 1598-9100
Titre abrégé: Intest Res
Pays: Korea (South)
ID NLM: 101572802
Informations de publication
Date de publication:
Jul 2023
Jul 2023
Historique:
received:
23
09
2022
accepted:
04
12
2022
medline:
10
2
2023
pubmed:
10
2
2023
entrez:
9
2
2023
Statut:
ppublish
Résumé
Thromboprophylaxis is recommended for hospitalized patients with inflammatory bowel disease (IBD) in Western countries, although it is selectively administered to high-risk patients in East Asia. A central venous catheter (CVC) is commonly placed in patients with IBD. Although CVC placement is considered a risk factor for venous thromboembolism (VTE), the degree of increased risk in patients with IBD is uncertain. This study aimed to identify the risk of VTE with CVC placement in hospitalized Japanese patients with IBD without thromboprophylaxis. This retrospective cohort study included patients with ulcerative colitis or Crohn's disease who were admitted for disease flares at Keio University Hospital between January 2016 and December 2020. Patients who already had thrombosis or were administered any antithrombotic treatment on admission were excluded. VTE development during the hospitalization was surveyed, and VTE risk associated with CVC indwelling was estimated using propensity score matching and inverse probability of treatment weighting analyses. Altogether, 497 hospitalized patients with IBD (ulcerative colitis, 327; Crohn's disease, 170) were enrolled. VTE developed in 9.30% (12/129) of catheterized patients and in 0.82% (3/368) of non-catheterized patients. The propensity score matching yielded 127 matched pairs of patients. The catheterized group demonstrated higher odds for VTE than the non-catheterized group (odds ratio, 13.15; 95% confidence interval, 1.68-102.70). A similar result was obtained in the inverse probability of treatment weighting analysis (odds ratio, 11.02; 95% confidence interval, 2.64-46.10). CVC placement is a major risk factor for VTE among hospitalized Japanese patients with IBD without thromboprophylaxis.
Sections du résumé
BACKGROUND/AIMS
OBJECTIVE
Thromboprophylaxis is recommended for hospitalized patients with inflammatory bowel disease (IBD) in Western countries, although it is selectively administered to high-risk patients in East Asia. A central venous catheter (CVC) is commonly placed in patients with IBD. Although CVC placement is considered a risk factor for venous thromboembolism (VTE), the degree of increased risk in patients with IBD is uncertain. This study aimed to identify the risk of VTE with CVC placement in hospitalized Japanese patients with IBD without thromboprophylaxis.
METHODS
METHODS
This retrospective cohort study included patients with ulcerative colitis or Crohn's disease who were admitted for disease flares at Keio University Hospital between January 2016 and December 2020. Patients who already had thrombosis or were administered any antithrombotic treatment on admission were excluded. VTE development during the hospitalization was surveyed, and VTE risk associated with CVC indwelling was estimated using propensity score matching and inverse probability of treatment weighting analyses.
RESULTS
RESULTS
Altogether, 497 hospitalized patients with IBD (ulcerative colitis, 327; Crohn's disease, 170) were enrolled. VTE developed in 9.30% (12/129) of catheterized patients and in 0.82% (3/368) of non-catheterized patients. The propensity score matching yielded 127 matched pairs of patients. The catheterized group demonstrated higher odds for VTE than the non-catheterized group (odds ratio, 13.15; 95% confidence interval, 1.68-102.70). A similar result was obtained in the inverse probability of treatment weighting analysis (odds ratio, 11.02; 95% confidence interval, 2.64-46.10).
CONCLUSIONS
CONCLUSIONS
CVC placement is a major risk factor for VTE among hospitalized Japanese patients with IBD without thromboprophylaxis.
Identifiants
pubmed: 36755496
pii: ir.2022.00116
doi: 10.5217/ir.2022.00116
pmc: PMC10397547
doi:
Types de publication
Journal Article
Langues
eng
Pagination
318-327Références
Intest Res. 2018 Apr;16(2):312-314
pubmed: 29743846
J Gastroenterol Hepatol. 2019 May;34(5):870-879
pubmed: 30225931
Am J Gastroenterol. 2008 Sep;103(9):2272-80
pubmed: 18684186
Circ J. 2011;75(5):1258-81
pubmed: 21441695
J Gastroenterol. 2021 Jun;56(6):489-526
pubmed: 33885977
Gastroenterology. 2014 Mar;146(3):835-848.e6
pubmed: 24462530
Am J Gastroenterol. 2019 Mar;114(3):384-413
pubmed: 30840605
Lancet. 2010 Feb 20;375(9715):657-63
pubmed: 20149425
Thromb Res. 2020 Mar;187:103-112
pubmed: 31981840
Nat Rev Gastroenterol Hepatol. 2021 Dec;18(12):857-873
pubmed: 34453143
J Gastroenterol. 2021 Dec;56(12):1062-1079
pubmed: 34611740
Pharm Stat. 2011 Mar-Apr;10(2):150-61
pubmed: 20925139
Thromb Haemost. 2001 Mar;85(3):430-4
pubmed: 11307809
Intest Res. 2019 Jan;17(1):63-69
pubmed: 30678446
Dis Colon Rectum. 2014 Dec;57(12):1379-83
pubmed: 25380003
Gut. 2011 Jul;60(7):937-43
pubmed: 21339206
Am J Cardiol. 2008 Dec 15;102(12):1711-7
pubmed: 19064029
Digestion. 2019;100(4):229-237
pubmed: 30554225
J Korean Med Sci. 2014 Feb;29(2):164-71
pubmed: 24550640
Inflamm Bowel Dis. 2018 Jul 12;24(8):1791-1800
pubmed: 29726897
Clin Gastroenterol Hepatol. 2014 Nov;12(11):1905-10
pubmed: 24632349
Gut. 2019 Dec;68(Suppl 3):s1-s106
pubmed: 31562236
Thromb Res. 2015 Mar;135(3):492-6
pubmed: 25596768
Clin Transl Gastroenterol. 2018 Apr 3;9(4):142
pubmed: 29618721
Intest Res. 2018 Jul;16(3):416-425
pubmed: 30090041
J Crohns Colitis. 2016 Mar;10(3):239-54
pubmed: 26614685
Am J Gastroenterol. 2021 Jul 1;116(7):1476-1484
pubmed: 33767104
Stat Med. 2010 Sep 10;29(20):2137-48
pubmed: 20108233
Stat Med. 2004 Oct 15;23(19):2937-60
pubmed: 15351954